Gleason Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9K Sell
164
-99
-38% -$7.98K ﹤0.01% 199
2026
Q1
$18.6K Buy
263
+101
+62% +$7.56K ﹤0.01% 155
2025
Q4
$12.8K Buy
162
+1
+0.6% +$79 ﹤0.01% 169
2025
Q3
$13.2K Sell
161
-25
-13% -$1.97K ﹤0.01% 156
2025
Q2
$14.9K Buy
186
+2
+1% +$154 ﹤0.01% 155
2025
Q1
$14.8K Buy
184
+1
+0.5% +$83 ﹤0.01% 153
2024
Q4
$15K Buy
+183
New +$15.2K ﹤0.01% 153

Other funds holding MET

Gleason Group's MET Position: Q2 2026 in Review

Gleason Group reduced its MetLife (MET) stake by 38% in Q2 2026, selling an estimated $7.98K and leaving 164 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #199.

Gleason Group first reported a position in MET in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.6K in Q1 2026. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Gleason Group held 164 shares of MetLife worth $13.9K as of Q2 2026.
  • Gleason Group sold 99 MetLife shares in Q2 2026, an estimated $7.98K.
  • MetLife made up ﹤0.01% of Gleason Group's portfolio in Q2 2026, its #199 holding.
  • Gleason Group first reported a position in MetLife in Q4 2024 and has held it in 7 quarters since.
  • Gleason Group's MetLife position peaked at $18.6K in Q1 2026.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.